Cromos Pharma, where the patients are

United States

Baxter to split into two independent companies, separating biopharmaceutical development and medical products

Thursday, March 27, 2014 02:55 PM

Deerfield, Ill.-based Baxter International plans to create two separate, independent global healthcare companies—one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products.

More... »

CRF Health eCOA webinar series

Chesapeake IRB acquires Goodwyn IRB

Thursday, March 27, 2014 09:39 AM

Chesapeake IRB has completed the acquisition of Goodwyn IRB.

More... »


BARDA awards SwRI $8.3M to continue developing cyanide poisoning antidote

Wednesday, March 26, 2014 11:45 AM

The U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) has awarded Southwest Research Institute (SwRI), an independent, nonprofit, applied R&D organization, an $8.3 million contract extension to continue development of a nasal-delivery, first-line treatment system to combat cyanide poisoning using an intranasal formulation of isoamyl nitrite.

More... »

PHT launches FDA Roadmap App for patient-focused outcome measurement

Wednesday, March 26, 2014 11:44 AM

Launched by PHT, a provider of technologies used to collect patient-driven eData for clinical research, the new FDA Roadmap App is the first mobile app designed to help sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials, released by the FDA in conjunction with its Clinical Outcome Assessment Qualification Program. The program and roadmap highlight the process by which a sponsor should consider, choose and/or develop a patient-focused outcome measurement strategy in a clinical program.

More... »

Fresenius launches rebranded Frenova Renal Research

Wednesday, March 26, 2014 11:37 AM

Fresenius Medical Care North America (FMCNA), a provider of dialysis services, has launched its newly branded Frenova Renal Research business, a phase I-IV drug and device clinical development partner dedicated exclusively to renal research.

More... »

CISCRP launches inaugural 5K run and walk

Tuesday, March 25, 2014 02:51 PM

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit, is launching an annual 5K run and walk event in San Diego this June to celebrate the volunteers who give the gift of participation in clinical research.

More... »

TKL Research opens new primary research clinic

Monday, March 24, 2014 02:41 PM

TKL Research, a full-service CRO, has officially opened its new primary research clinic in Fair Lawn, N.J. This 25,000-square-foot facility offers a 70% increase in space over TKL’s former clinic, making it possible to create a sophisticated 30-bed phase I pharmacology unit and multiple examination rooms for outpatient studies.

More... »

Lupus Foundation of America launches new monitoring tool

Thursday, March 20, 2014 02:42 PM

The Lupus Foundation of America is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the Rapid Evaluation of Activity in Lupus (LFA-REAL) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential to greatly improve medical care and quality of life for people living with the autoimmune disease.

More... »

Cord Blood Registry partners with two universities for cerebral palsy innovation

Thursday, March 20, 2014 02:38 PM

Cord Blood Registry (CBR), a newborn stem cell company, is partnering with the University of Texas Health Science Center at Houston and Georgia Regents University to establish FDA-regulated clinical trials investigating whether an intravenous infusion of a child's own cord blood cells, banked at the time of their birth, will lessen the symptoms of cerebral palsy.

More... »

FDA approves Impavido to treat tropical disease leishmaniasis

Thursday, March 20, 2014 11:40 AM

The FDA has approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is a disease caused by Leishmania, a parasite which is transmitted to humans through sand fly bites. The disease occurs primarily in people who live in the tropics and subtropics. Most U.S. patients acquire leishmaniasis overseas.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs